12h
GlobalData on MSNFDA puts clinical hold on BioNTech’s malaria vaccine trialThe FDA has ordered BioNTech to immediately halt its Phase I/II trial of malaria vaccine candidate BNT165e, pending changes.
Income tax expense increased by $6.7 million in 2024 compared to 2023, primarily due to an increase in U.S. taxes under the ...
Discover 7 biotech companies in Taiwan, a rising regional player in precision medicine, immunotherapy, and drug development!
Gireesh Babu, New Delhi Wednesday, March 5, 2025, 14:45 Hrs [IST] With the registration of clinical research organisations (CROs) to b ...
Strategic collaboration harnesses GATC's proprietary Artificial Intelligence-powered, validated Multiomics Advanced Technologyâ„¢ platform to rapidly optimize and derisk drug discovery and development, ...
The new formulation of Keytruda, currently under FDA review, is sparking conflict with Halozyme, which makes enzymes that ...
Drugs in late-stage development may mean competition on price for two Pfizer medications that, by some accounts, are the most expensive cardiac medications in history.
10h
TipRanks on MSNBiotech Alert: Searches spiking for these stocks todayThese names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...
A new drug that works against the main types of primary bone cancer has been developed by researchers at the University of ...
The company has asked the U.S. patent office to reconsider patents that could prevent it from selling a new version of its ...
Merck's injected version of its blockbuster cancer drug Keytruda could face a potential patent challenge from biotech ...
10h
News Medical on MSNNew drug VIP36 shows promise in treating pain without harmful side effectsA research team funded by the National Institutes of Health (NIH) has developed a medication that shows promise in treating acute and chronic pain.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results